# Purged Circulating Tumor Cells (CTCs) From Metastatic Breast Cancer

> **NCT00429182** · PHASE2 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 32 (actual)

## Conditions studied

- Breast Cancer
- Metastatic Breast Carcinoma
- Invasive Breast Carcinoma

## Interventions

- **DRUG:** Carboplatin
- **DRUG:** Cyclophosphamide
- **DRUG:** Thiotepa
- **PROCEDURE:** Stem Cell Transplant

## Key facts

- **NCT ID:** NCT00429182
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2012-02
- **Final completion:** 2012-02
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2013-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00429182

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00429182, "Purged Circulating Tumor Cells (CTCs) From Metastatic Breast Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00429182. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*